101122 Alachua Open House Banner

Reserve Your Digital Seat

Home to our Development and Manufacturing Center for Biologics, Vaccines, and Gene Therapy, our Alachua site is answering the call to revolutionize how medicines are made, funded, and scaled.

Sign up to hear from site leaders and virtually tour our recently built process and analytical development laboratory and GMP manufacturing facility which includes four additional 2,000L single-use bioreactors. 

Date + Time

Tuesday, October 11th, 2022

11:00 AM - 12:00 PM ET



Company and Site Introduction
Process and Analytical Development
Manufacturing with Virtual Tour of Expansion
Q+A with Panel of Experts

Leadership Team 

Stewart McNaull
VP & Business Head of Vaccines and Biologics Franchises

Oliver Vogt
VP & GM Site Head

Suzanne Mace
Head of Process Development

Chuck Hart
Head of Manufacturing

Adam Pinkert
Head of Quality


Technical Highlights

  • Bioanalytical development and testing
  • Process development and characterization
  • Stability services
  • Suspension cell and adherent cell reactor technologies
  • Plasmid production, vector development, viral banking
  • cGMP manufacturing (50L to 2000L) across biologics, vaccines, and gene therapy
  • BSL3 capability
  • Clinical fill/finish
  • Regulatory services (IND, BLA)